Adverse consequences of motility effects of GLP-1RAs In one study, the incidence of retained gastric contents in individuals using a GLP-1RA was 56%, compared with 19% for those not using GLP-1RAs (34), although notably there were more individuals with T2D and obesity in the group treated with GLP-1RAs
It is worth mentioning that long-acting agents have been associated with less nausea and vomiting but with more diarrhoea [30], which might be explained by a more sustained effect of these compounds on GLP-1 intestinal receptors [31]
If your sulfur burps are severe, persistent beyond 8 to 12 weeks of treatment, and accompanied by significant bloating and abdominal discomfort, ask your doctor about testing for SIBO
That is significantly more restrictive than the FDA threshold
Book a free 15-min consult Check my benefits or call (877) 658-2244 4.8 Trusted by 4,500+ seniors across 35 states Book your free 15-minute consult Pick a time that suits you and a member of our care team will call you
Figure S5